This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Stocks to Watch: Knight Capital, Chesapeake

Stocks in this article: KCG LVS CHK TSN TEVA AMTD JEF

NEW YORK -- Knight Capital Group (KCG - Get Report) is discussing a possible rescue involving TD Ameritrade (AMTD), Getco and other investors, according to a report.

Under the plan being discussed, TD Ameritrade and Getco would be the primary investors in a consortium of more than six entities that would provide a total of $400 million in capital to Knight, The Wall Street Journal reported.

A Knight representative declined to comment, the Journal said.

Knight, the Jersey City, N.J-based market maker, last Wednesday suffered a software glitch that caused it to send out erroneous trading orders. On Thursday, the company announced it had suffered a $440 million pretax loss as a result.

Under the consortium plan, the investors would purchase debt that would convert into stock at $2.50 a share, the Journal report said.

Jefferies (JEF) also is involved in setting up the arrangement, the report said.

Knight in Talks on Potential Rescue: Report


Chesapeake Energy (CHK - Get Report) is expected by analysts Monday to post fiscal third-quarter earnings of 8 cents a share on revenue of $2.5 billion.


Tyson TSN (TSN - Get Report), the meat and chicken processor, is expected Monday to post a profit of 55 cents a share on revenue of $8.75 billion.


Earnings are also expected Monday from Dillard's (DDS), Cache (CACH) and Cognizant Technology (CTSH).


The U.S. attorney's office in Los Angeles is investigating whether Las Vegas Sands (LVS - Get Report) violated money-laundering laws by not reporting money transfers to its casinos from two big gamblers, according to the Journal.

Las Vegas Sands Target of Federal Probe: Report


Teva Pharmaceutical (TEVA), the Israeli generic drugmaker, is being investigated by the Securities and Exchange Commission for possible violations of a U.S. antibribery law.


-- Written by Joseph Woelfel



>To contact the writer of this article, click here: Joseph Woelfel

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,412.64 -266.06 -1.50%
S&P 500 2,033.34 -23.75 -1.15%
NASDAQ 4,698.2630 -73.50 -1.54%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs